The Pennant (US:PNTG) ZACKS·2025-05-07 00:31Core Insights - The Pennant Group, Inc. reported $209.84 million in revenue for Q1 2025, marking a year-over-year increase of 33.7% and exceeding the Zacks Consensus Estimate by 3.68% [1] - The company's EPS for the same period was $0.27, up from $0.20 a year ago, representing a surprise of 22.73% over the consensus estimate of $0.22 [1] Revenue Breakdown - Total home health and hospice services revenue reached $159.87 million, surpassing the average estimate of $151.45 million, with a year-over-year change of 37.2% [4] - Senior living services generated $49.97 million, exceeding the average estimate of $47.98 million, reflecting a year-over-year increase of 23.6% [4] - Home care and other services within home health and hospice reported $15.17 million, significantly higher than the estimated $12.57 million, showing a remarkable year-over-year change of 224.7% [4] - Hospice services revenue was $70.59 million, compared to the average estimate of $68.61 million, indicating a year-over-year increase of 29.3% [4] - Home health services generated $74.12 million, exceeding the estimated $70.28 million, with a year-over-year change of 29.6% [4] Stock Performance - Shares of The Pennant Group have returned +9.8% over the past month, while the Zacks S&P 500 composite has changed by +11.5% [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential outperformance against the broader market in the near term [3]